Results 171 to 180 of about 12,956 (210)
Some of the next articles are maybe not open access.
Analytical Biochemistry, 1972
Abstract A procedure for determining the buoyant density of nucleic acids and/or other biological macromolecules using the preparative ultracentrifuge and a recording spectrophotometer via a specially adapted tube holder is described. The procedure gives buoyant density values, precise to ±0.004 gm cm −3 , which is comparable to determinations made ...
J L, Olpin, C L, Burger
openaire +2 more sources
Abstract A procedure for determining the buoyant density of nucleic acids and/or other biological macromolecules using the preparative ultracentrifuge and a recording spectrophotometer via a specially adapted tube holder is described. The procedure gives buoyant density values, precise to ±0.004 gm cm −3 , which is comparable to determinations made ...
J L, Olpin, C L, Burger
openaire +2 more sources
Treatment of feline leukemia virus (FeLV) infection
Veterinary Microbiology, 1999FeLV infection is still considered to account for most disease-related deaths in pet cats. Different treatment attempts with various drugs were performed in the past but none resulted in healing or complete virus elimination. Therefore, it caused a sensation when Horber and Mayr [Horber, D., Mayr, B., 1991. Prax.
K, Hartmann +5 more
openaire +2 more sources
The epidemiology of the feline leukemia virus (FeLV)
Cancer, 1977Clustering of cases of feline lymphosarcoma (LSA) has been observed by veterinarians for many years. In 1964 it was discovered that feline LSA was caused by an oncornavirus, the feline leukemia virus (FeLV). In 1970, a simple, indirect immunoflourescent antibody (IFA) test for FeLV was developed which enabled large numbers of cats, living in their ...
W D, Hardy +5 more
openaire +2 more sources
Antiviral Research, 1989
2',3'-dideoxycytidine (ddC) inhibits replication of the immunodeficiency inducing strain of feline leukemia virus (FeLV-FAIDS) in vitro at concentrations ranging from 1-10 micrograms/ml. Additive antiviral effect is achieved when ddC is combined with either human recombinant alpha interferon (IFN alpha) or tumor necrosis factor (TNF) plus IFN alpha ...
N S, Zeidner +5 more
openaire +2 more sources
2',3'-dideoxycytidine (ddC) inhibits replication of the immunodeficiency inducing strain of feline leukemia virus (FeLV-FAIDS) in vitro at concentrations ranging from 1-10 micrograms/ml. Additive antiviral effect is achieved when ddC is combined with either human recombinant alpha interferon (IFN alpha) or tumor necrosis factor (TNF) plus IFN alpha ...
N S, Zeidner +5 more
openaire +2 more sources
[Feline leukemia virus (FeLV) and FeLV-associated diseases in cats: a review].
Tijdschrift voor diergeneeskunde, 1987Feline leukaemia virus (FeLV) usually occurs in its natural species, the domestic cat. FeLV is also important to human individuals as a comparative model, as FeLV may cause a variety of diseases which are partly malignant and partly benign, such as immunosuppression which bears a resemblance to AIDS (acquired immune deficiency syndrome) in man ...
K, Weijer, F, UytdeHaag, A D, Osterhaus
openaire +1 more source
FeLV and FIV in a cat population
Veterinary Record, 2007SIR, — For the past eight years the Strathbogie Veterinary Centre in Huntly has recorded the geographical location of the majority of cats that were found positive on the snap idexx test for feline leukaemia virus (felv) antigen or feline immunodeficiency virus (fiv) antibody.
openaire +2 more sources